Silicon Laboratories INC

Silicon Labs announced robust second-quarter 2026 financial results, featuring $228 million in revenue and a significant surge in non-GAAP diluted earnings per share.

Silicon Laboratories Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired, moving closer to its acquisition by Texas Instruments.

Silicon Labs announced first quarter 2026 revenue of $214 million, a 20% year-over-year increase, with non-GAAP EPS of $0.53, while noting progress on its proposed merger with Texas Instruments.

Silicon Laboratories Inc. announced that its stockholders overwhelmingly approved the merger agreement with Texas Instruments Incorporated at a special meeting held on April 30, 2026.

Silicon Laboratories Inc. announced the results of its Annual Meeting of Stockholders held on April 23, 2026, including the election of directors and ratification of its accounting firm.

Silicon Labs announced robust financial results for fiscal year 2025, including 34% year-over-year revenue growth, alongside the suspension of guidance due to a pending acquisition by Texas Instruments.

Silicon Laboratories Inc. (SLAB) reported increased revenues for the quarter ended July 4, 2026, but also a net loss, with significant merger-related costs impacting operating expenses.

Silicon Laboratories Inc. reported a significant increase in revenues and a substantial reduction in net loss for the quarter and nine months ended October 4, 2025, driven by improved demand in Industrial & Commercial and Home & Life segments.

Silicon Laboratories Inc. reported significantly reduced net and operating losses, strong revenue growth, and positive operating cash flow for the second quarter and first half of fiscal 2025, driven by improved demand and inventory management.

Silicon Laboratories' Q1 2025 shows significant revenue growth driven by both Industrial & Commercial and Home & Life product categories, alongside a reduction in operating losses.

Silicon Laboratories Inc. reported a decrease in revenue and a net loss for the third quarter of 2024, impacted by macroeconomic conditions and reduced demand.

Silicon Laboratories Inc. reported a significant decrease in revenue and a net loss for the second quarter of 2024, impacted by a softening market and reduced customer demand.

Silicon Laboratories Inc. announced its definitive merger agreement with Texas Instruments, where it will be acquired for $231.00 per share in cash, with the transaction expected to close in the first half of 2027.

Silicon Laboratories Inc. reports a decrease in revenue and an operating loss for fiscal year 2024, impacted by a semiconductor industry downturn and customer inventory reductions.

Silicon Laboratories' 10-K filing reveals a challenging fiscal year 2023 marked by revenue decline and a material weakness in internal controls, amidst a broader semiconductor industry downturn.

Robert J Conrad, Sr VP and General Manager of Silicon Laboratories Inc., sold 6,581 shares of common stock on August 14, 2026 for $218.21 per share.

Silicon Laboratories Inc. (SLAB) CFO Dean Warren Butler reported a disposition of 6,291 shares of common stock on May 15, 2026, to cover tax obligations upon the vesting of a previously awarded equity grant.

Silicon Laboratories Inc. reports a Form 4 filing detailing a transaction by Sr VP Robert J Conrad.

Silicon Laboratories Inc. reports a Form 4 filing detailing stock transactions by President & CEO Robert Matthew Johnson.

Silicon Laboratories Inc. Chief Accounting Officer Mark D. Mauldin reported a transaction involving the withholding of shares to cover taxes upon the vesting of an equity award.

Brandon Tolany, Sr. VP WW Sales & Marketing at Silicon Laboratories Inc., reported a transaction involving the sale of 4,160 shares of common stock.

Silicon Laboratories Inc. will hold its annual stockholders meeting on April 24, 2025, to elect directors, ratify the appointment of auditors, approve executive compensation, and consider amendments to the company's certificate of incorporation.

Silicon Laboratories Inc. is soliciting proxies for its 2025 Annual Meeting, focusing on director elections, auditor ratification, executive compensation, and amendments to the company's charter.

Silicon Laboratories Inc. will hold its annual stockholders meeting on April 18, 2024, to elect directors, ratify the appointment of Ernst & Young LLP, and vote on executive compensation.

Silicon Laboratories Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on April 18, 2024, featuring proposals for director elections, ratification of the accounting firm, and an advisory vote on executive compensation.

Vanguard Capital Management has reported a beneficial ownership of 5.23% in Silicon Laboratories Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.57% in Silicon Laboratories Inc. common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Silicon Laboratories Inc. common stock following an internal realignment.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 2.1% beneficial ownership stake in Silicon Laboratories Inc. as of February 27, 2026.

Capital Research Global Investors has reported a 3.7% beneficial ownership stake in Silicon Laboratories Inc., holding 1,206,937 shares of common stock.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.5% beneficial ownership stake in Silicon Laboratories Inc., totaling over 4 million shares.